Related Experiment Videos

Innovative drug treatments for viral and autoimmune myocarditis

William H Frishman1, Miechelle O'Brien, Nauman Naseer

  • 1Department of Medicine and Pharmacology, New York Medical College, Valhalla, NY 10595, USA.

Heart Disease (Hagerstown, Md.)
|May 25, 2002
PubMed

Insights

Myocarditis, a common cause of cardiomyopathy, is hard to detect early. Current treatments manage heart failure, but new therapies are under investigation for myocarditis itself.

Area of Science:

  • Cardiology
  • Immunology

Background:

  • Myocarditis is a significant cause of cardiomyopathy, potentially accounting for 25% of human cases.
  • Clinical detection of myocarditis before myopathic changes is challenging.
  • Standard heart failure management involves diuretics, digoxin, ACE inhibitors, ARBs, and beta-blockers.

Purpose of the Study:

  • To review current management strategies for myocarditis and associated heart failure.
  • To highlight emerging therapeutic approaches for myocarditis.
  • To emphasize the need for improved early detection and etiological differentiation of myocarditis.

Main Methods:

  • Literature review of myocarditis diagnosis and treatment.
  • Analysis of current and investigational therapies for myocarditis.
  • Discussion of challenges in clinical detection and differential diagnosis.

Main Results:

  • Standard heart failure regimens are used for myocarditis-induced heart failure.
  • Numerous treatments are under investigation for myocarditis, including immunosuppressants, anti-inflammatories, and antivirals.
  • Early detection and distinguishing between viral and autoimmune causes remain critical unmet needs.

Conclusions:

  • Effective management of myocarditis-induced heart failure relies on standard therapies.
  • Investigational treatments show promise but require further study.
  • Advancing early diagnostic tools and etiological classification is crucial for optimal patient care.

Related Concept Videos

Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
209
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
178
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
374
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
316
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
269
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.3K